Literature DB >> 737909

Complement, lymphocytotoxins and immune complexes in infectious mononucleosis: serial studies in uncomplicated cases.

J A Charlesworth, J W Quin, G J Macdonald, R J Lennane, C R Boughton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 737909      PMCID： PMC1537497     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  18 in total

1.  MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS.

Authors:  P I TERASAKI; J D MCCLELLAND
Journal:  Nature       Date:  1964-12-05       Impact factor: 49.962

2.  Precise standardization of reagents for complement fixation.

Authors:  J F KENT; E H FIFE
Journal:  Am J Trop Med Hyg       Date:  1963-01       Impact factor: 2.345

3.  Phagocytosis of particulate complexes of gamma-globulin and rheumatoid factor.

Authors:  R L PARKER; F R SCHMID
Journal:  J Immunol       Date:  1962-04       Impact factor: 5.422

Review 4.  The oncogenicity of Epstein-Barr virus.

Authors:  G Miller
Journal:  J Infect Dis       Date:  1974-08       Impact factor: 5.226

5.  Patterns of antibodies to Epstein-Barr virus-induced early antigens in Burkitt's lymphoma. Comparison of dying patients with long-term survivors.

Authors:  W Henle; G Henle; P Gunvén; G Klein; P Clifford; S Singh
Journal:  J Natl Cancer Inst       Date:  1973-05       Impact factor: 13.506

6.  Mechanisms involved in the deposition of immune complexes in tissues.

Authors:  C G Cochrane
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

7.  Antibody formation in infectious mononucleosis. II. Other 19S antibodies and false-positive serology.

Authors:  R L Carter
Journal:  Br J Haematol       Date:  1966-05       Impact factor: 6.998

8.  Immunoglobulin classes of DNA binding activity in serum and skin in systemic lupus erythematosus.

Authors:  J B Pennebaker; J N Gilliam; M Ziff
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

9.  X-linked recessive progressive combined variable immunodeficiency (Duncan's disease).

Authors:  D T Purtilo; C K Cassel; J P Yang; R Harper
Journal:  Lancet       Date:  1975-04-26       Impact factor: 79.321

10.  C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT.

Authors:  H J MUELLER-EBERHARD; I H LEPOW
Journal:  J Exp Med       Date:  1965-05-01       Impact factor: 14.307
View more
  10 in total

1.  Serum complement components in patients with trachoma.

Authors:  D K Sen; G S Sarin; M Hiranandani; U K Baveja
Journal:  Br J Ophthalmol       Date:  1985-09       Impact factor: 4.638

Review 2.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

3.  Serum complement component depression during acute adenovirus conjunctivitis.

Authors:  A K Gupta; G S Sarin
Journal:  Br J Ophthalmol       Date:  1984-05       Impact factor: 4.638

4.  Increased IgM and IgM immune complex-like material in the circulation of renal transplant recipients with primary cytomegalovirus infections.

Authors:  W M Baldwin; A van Es; R M Valentijn; G W van Gemert; M R Daha; L A Vanes
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

5.  Circulating immune complexes in patients with acute measles and rubella virus infections.

Authors:  B Ziola; G Lund; O Meurman; A Salmi
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

6.  Failure to detect brain reactivity of lymphocytotoxins in cerebral lupus.

Authors:  B A Pussell; F Blyth; J A Charlesworth
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

7.  In vivo modulation of polyclonal activation of lymphocytes by SOAz, a cyclophosphazene derived drug. Prevention of murine glomerulonephritis induced by chronic injections of lipopolysaccharide.

Authors:  M Dueymes; G J Fournie; F Carentz; M Mignon-Conte; J F Labarre; J J Conte
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

8.  Studies of lymphocytotoxins in infectious mononucleosis and systemic lupus erythematosus: evidence for immune complex-mediated cytotoxicity.

Authors:  J W Quin; J A Charlesworth; C Bowman; G J Macdonald
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

9.  Studies of lymphocytotoxins in infectious mononucleosis: reduced lymphocyte killing in the acute phase.

Authors:  J W Quin; J A Charlesworth; C H Lee; G J Macdonald
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

10.  Lymphocyte transformation induced by autologous cells. VIII. Impaired autologous mixed lymphocyte reactivity in patients with acute infectious mononucleosis.

Authors:  C E Moody; B A Casazza; W N Christenson; M E Weksler
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.